← FDA Drug Approvals (Drugs@FDA)

CHOLESTYRAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2018-07-02

Drug application

FDA Application #
ANDA202901
Application type
Abbreviated New Drug Application (Generic)
Brand name
CHOLESTYRAMINE
Generic name
CHOLESTYRAMINE
Active ingredients
CHOLESTYRAMINE
Dosage form
POWDER
Route
ORAL
Marketing status
Prescription
Sponsor
ZYDUS PHARMS
Manufacturer
Zydus Pharmaceuticals (USA) Inc.
First approval
2018-07-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown